Skip to content
OpenCapital
Get started

Microbot Medical MBOT Q3 2025 earnings

Reported November 12, 2025 · Before market open

Diluted EPS-$0.07Miss by $0.01
Revenue estimate$600.0K
EPS estimate-$0.06

Next report

Aug 11, 2026 (in a month)
Revenue estimate$583.3K
EPS estimate-$0.09

Financials

Q3 2025

Income statement

See full
Operating income-$3.9M-17.0%
Net income-$3.6M-11.3%
EPS (diluted)-$0.07+65.0%

Balance sheet

See full
Cash & equivalents$6.8M+1,182%
Total debt$899.0K+856%
Total equity$78.2M+1,954%
Total assets$81.8M+1,470%

Cash flow

See full
Operating cash flow-$3.8M-39.2%
CapEx$13.0K—
Free cash flow-$3.9M-39.7%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$161.02M+991%
Enterprise value$155.17M+983%

Returns & leverage

See full
Return on equity-31.9%-14.6pp
Debt / equity0×0.0×
Current ratio27.5×+23.9×

Versus estimates

Revenue

Q1 2026$105.0KMiss by $195.0K

Diluted EPS

Q1 2026-$0.05Beat by $0.03Q4 2025-$0.04Beat by $0.02
Q3 2025-$0.07Miss by $0.01
Q2 2025-$0.10Miss by $0.02Q1 2025-$0.08Beat by $0.05Q4 2024-$0.20Miss by $0.02

Ask the moment Microbot Medical reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Microbot Medical report Q3 2025 earnings?
Microbot Medical (MBOT) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Microbot Medical's Q3 2025 revenue and EPS?
Microbot Medical reported diluted EPS of $-0.07 for Q3 2025.
Did Microbot Medical beat estimates in Q3 2025?
EPS missed the consensus estimate of $-0.06 by $0.01.
How did Microbot Medical's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 65.0% from $-0.20.
Where can I find Microbot Medical's Q3 2025 SEC filings?
You can read the 10-Q periodic report (0001493152-25-021929) directly on SEC EDGAR. The filing index links above go to sec.gov.